A woman whose mother, aunt and grandmother died from Huntington's disease has described a breakthrough in treating the ...

One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of ...

As well as slowing disease progression by 75 percent at 36 months, the scientists found that neurofilament light protein (NfL)—a biomarker of neuronal damage—levels in spinal fluid were lower in ...

Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...

“Beyond UniQure, the pipeline includes highly promising approaches that will ideally move the goal from merely managing ...

An experimental gene therapy slowed Huntington’s by up to 75 percent in a small clinical trial. While not a cure, it may give patients longer lives.

UniQure's therapy, called AMT-130, reduced disease progression by 75% at 36 months in patients who received a high dose.

Sex influences how genetic and age-related factors translate into clinical and neuroimaging trajectories in Huntington disease.

Analysis of Enroll-HD shows smoking is linked to earlier Huntington’s disease onset in women and faster motor and cognitive ...